Skip to main content

Month: July 2025

Heineken Holding N.V. reports 2025 half year results

  Amsterdam, 28 July 2025 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) announces: Solid profit growth highlighting agility across HEINEKEN’s global footprint   Key Highlights   The net result of Heineken Holding N.V.’s participating interest in Heineken N.V. for the first half year of 2025 amounts to €380 million.Revenue €16,924 millionNet revenue (beia) 2.1% organic growth; per hectolitre 3.3%Beer volume organic growth -1.2%; Heineken® volume growth 4.5%Operating profit €1,433 million; operating profit (beia) organic growth 7.4%Outlook for the full year unchanged; operating profit (beia) expected to grow organically 4% to 8%  Enquiries     Media Heineken Holding N.V.        Kees Jongsma ...

Continue reading

Heineken N.V. reports 2025 half year results

Amsterdam, 28 July 2025 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces: Solid profit growth highlighting agility across our global footprint  Key HighlightsRevenue €16,924 million Net revenue (beia) 2.1% organic growth; per hectolitre 3.3%Beer volume organic growth -1.2%; Heineken® volume growth 4.5%Operating profit €1,433 million; operating profit (beia) organic growth 7.4%Diluted EPS (beia) €2.08Outlook for the full year unchanged; operating profit (beia) expected to grow organically 4% to 8%  CEO StatementDolf van den Brink, CEO and Chairman of the Executive Board, commented: “In the first half, we delivered solid results as organic operating profit (beia) grew 7.4% as the operating margin expanded by 26 bps and net revenue (beia) increased 2.1%. At the same...

Continue reading

Perseus Mining June Quarter Report

Perth, July 28, 2025 (GLOBE NEWSWIRE) — JUNE 2025 QUARTER REPORT Continued strong performance of Perseus Mining’s operations grows cash & bullion balance to US$827 million PERTH, Western Australia/July 28, 2025/Perseus Mining Limited (“Perseus” or the “Company”) (TSX & ASX: PRU) reports on its activities for the three months’ period ended June 30, 2024 (the “Quarter”). Below is a summary of the release. The full report is available at www.perseusmining.com, www.sedarplus.ca and www.asx.com.au.Key operating indicators and highlights for the June 2025 quarter (Q4 FY25) include:PERFORMANCE INDICATOR  UNIT  MARCH 2025  QUARTER  JUNE 2025  QUARTER  JUNE 2025  HALF YEAR  2025   FINANCIAL YEAR  Gold recovered  Ounces   121,605    121,237    242,843    496,551  Gold poured  Ounces   122,915    119,868    242,782    495,984  Production...

Continue reading

WeRide Wins Permit for Autonomous Robotaxi Service in Shanghai, Partnering with Chery to Revolutionize Urban Mobility

SHANGHAI, China, July 26, 2025 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD), a global leader of autonomous driving technology, has been granted a permit from the Shanghai municipal government to operate regulation-compliant, Level 4 (L4) autonomous Robotaxi ride-hailing services. Issued during the World Artificial Intelligence Conference (WAIC 2025) in Shanghai, the permit enables WeRide, in partnership with Chery Group and Jinjiang Taxi, to deploy Robotaxis on public roads in Pudong New Area. This milestone also marks the WeRide Robotaxi’s official entry into its tenth city globally. As part of WAIC’s Level 4 Intelligent Vehicle Experience Showcase, the three partners jointly launched the event’s only fully mass-produced, pre-installed L4 Robotaxi shuttle service. The service connects key Shanghai transport hubs and cultural-tourism...

Continue reading

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase inhibitor candidates – – Preclinical data and U.S. genital herpes prevalence and treatment patterns also highlighted – – Interim proof-of-concept Phase 1b data in participants with recurrent genital herpes expected for both candidates in fall 2025 – SOUTH SAN FRANCISCO, Calif., July 26, 2025 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced Phase 1a clinical and preclinical data for its herpes simplex virus (HSV) helicase-primase inhibitor candidates ABI-5366 and ABI-1179 are featured in multiple poster presentations, including one late-breaker, during the STI &...

Continue reading

PONY AI Inc. Among the First to Receive Permit for Fully Driverless Commercial Robotaxi Services Shanghai’s Pudong New Area

SHANGHAI, China, July 26, 2025 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced that it has received a permit to provide fully driverless commercial Robotaxi services of Shanghai’s Pudong New Area, issued at the World Artificial Intelligence Conference (“WAIC”) 2025. This achievement demonstrates not only increasing regulatory trust and recognition in the Company’s technology and safety standards, but also represents another major milestone in advancing Robotaxi commercialization in a top-tier urban market in China. Pony.ai is among the first companies to receive this approval, making it the only company with fully driverless commercial Robotaxi service permits in all four of China’s tier-one cities—Beijing,...

Continue reading

CORRECTION: Paul Mueller Company Announces Its Second Quarter Earnings of 2025

SPRINGFIELD, Mo., July 25, 2025 (GLOBE NEWSWIRE) — Paul Mueller Company (OTC: MUEL) corrects an earlier release which contained an error in the earnings per share for the three and six months ended June 30, 2025.PAUL MUELLER COMPANY                         SIX-MONTH REPORTUnaudited(In thousands)CONSOLIDATED STATEMENTS OF INCOME                             Three Months Ended   Six Months Ended   Twelve Months Ended    June 30   June 30   June 30    2025   2024     2025       2024       2025       2024                           Net Sales   $ 72,624   $ 65,670   $ 131,484     $ 116,026     $ 264,043     $ 228,900  Cost of Sales     44,760     45,871     85,798       80,431       171,491       158,123  Gross Profit   $ 27,864   $ 19,799   $ 45,686     $ 35,595     $ 92,552     $ 70,777  Selling,...

Continue reading

Traction Uranium Announces LIFE Offering for up to C$833,400

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, July 25, 2025 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce that it intends to complete a private placement financing (the “Offering”) of units (each, a “Unit”) at a price of C$0.18 per Unit, with each Unit being comprised of one common share (each, a “Share”) and one Share purchase warrant (“Warrant”). Each Warrant will be entitling the holder to purchase one Share at a price of C$0.24 during the period between the date that is 60 days from Closing (as defined below) and the date that is 24 months from Closing. Closing of the Offering is anticipated to occur on or about August 8, 2025 (“Closing”). The Company notes that it will only complete...

Continue reading

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) — Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, announced today that leading independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) recommended that Regional shareholders vote “FOR”: (1) the approval of the Amended and Restated Agreement and Plan of Merger, dated April 14, 2025 (as amended, the “Merger Agreement”), by and between Regional and SunLink Health Systems, Inc. (the “Merger Proposal”), (2) the approval of the issuance of shares of Regional common stock and Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the “Regional Series D preferred...

Continue reading

Grupo Bafar Reports Second quarter 2025 Results

CHIHUAHUA, México, July 25, 2025 (GLOBE NEWSWIRE) — Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading and benchmark company in the national food sector, announced its results for the second quarter of 2025, highlighting sustained growth driven by innovation, digitalization, and expansion strategies across all its divisions. Second Quarter 2025 HighlightsNet sales: $7,931 million of pesos, with a growth of 15.5%. Operating income: $1,439 million of pesos, with an operating margin of 18.1%. EBITDA: $1,696 million of pesos, with a registered growth of 13.8%. Net income: $1,580 million of pesos, with a net margin of 19.9%.During the quarter, Grupo Bafar maintained its trajectory of growth and rentability, outperforming again its historic record in quarterly earnings. This performance was a result of a combination of greater...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.